ArticleOncoTargets and therapy2015

A case of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with MET amplification and epithelial-to-mesenchymal transition.

Seigo Miyoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.